Patents by Inventor Salvador FUDIO MUÑOZ

Salvador FUDIO MUÑOZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230295236
    Abstract: The present invention relates to the use of compounds in the treatment of inflammation, preferably inflammation associated with activation of Toll-like receptors. The invention also relates to the use of compounds to treat pathogen-induced inflammation.
    Type: Application
    Filed: March 2, 2021
    Publication date: September 21, 2023
    Inventors: Pablo AVILÉS MARÍN, Alejandro LOSADA GONZÁLEZ, José María FERNÁNDEZ SOUSA-FARO, Salvador FUDIO MUÑOZ
  • Publication number: 20230158103
    Abstract: The use of PLD with one or more further CoV antiviral agent(s) in the treatment of coronavirus (CoV) infection.
    Type: Application
    Filed: March 2, 2021
    Publication date: May 25, 2023
    Inventors: Nuria IZQUIERDO-USEROS, Júlia VERGARA-ALERT, Pablo AVILÉS MARÍN, Alejandro LOSADA GONZÁLEZ, José María FERNÁNDEZ SOUSA-FARO, Salvador FUDIO MUÑOZ
  • Publication number: 20230158102
    Abstract: A compound of general formula (I) wherein X, Y, n, p, q, and R1-R17 take various meanings, for use in the treatment of Coronavirus infection.
    Type: Application
    Filed: March 2, 2021
    Publication date: May 25, 2023
    Inventors: José María FERNÁNDEZ SOUSA-FARO, Pablo AVILÉS MARÍN, Alejandro LOSADA GONZÁLEZ, Salvador FUDIO MUÑOZ
  • Publication number: 20230159594
    Abstract: The present invention relates to the use of compounds in the treatment of a viral infection, wherein the virus is selected from the Orthomyxoviridae family or wherein the virus is West Nile virus.
    Type: Application
    Filed: March 2, 2021
    Publication date: May 25, 2023
    Inventors: Pablo AVILÉS MARÍN, Alejandro LOSADA GONZÁLEZ, José María FERNÁNDEZ SOUSA-FARO, Salvador FUDIO MUÑOZ